How big is Relmada Therapeutics, Inc.?

Jun 22 2025 06:07 PM IST
share
Share Via
As of Jun 18, Relmada Therapeutics, Inc. has a market capitalization of 23.37 million, with net sales of 0.00 million and a net profit of -75.72 million over the latest four quarters. Shareholder's funds are at 35.52 million, and total assets are 45.82 million.
As of Jun 18, Relmada Therapeutics, Inc. has a market capitalization of 23.37 million, categorizing it as a Micro Cap company.

As of Jun 18, the sum of Net Sales for the latest four quarters is 0.00 million, while the sum of Net Profit for the same period is -75.72 million.

As of Dec 24, the reporting period shows Shareholder's Funds at 35.52 million and Total Assets at 45.82 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
What does Relmada Therapeutics, Inc. do?
Jun 22 2025 06:52 PM IST
share
Share Via